{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:56:56Z","timestamp":1792457816742,"version":"4.5.0"},"reference-count":44,"publisher":"American Society of Hematology","issue":"16","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Preliminary data and clinical experience have suggested an increased risk of abnormal uterine bleeding (AUB) in women of reproductive age treated with anticoagulants, but solid data are lacking. The TEAM-VTE study was an international multicenter prospective cohort study in women aged 18 to 50 years diagnosed with acute venous thromboembolism (VTE). Menstrual blood loss was measured by pictorial blood loss assessment charts at baseline for the last menstrual cycle before VTE diagnosis and prospectively for each cycle during 3 to 6 months of follow-up. AUB was defined as an increased score on the pictorial blood loss assessment chart (&amp;gt;100 or &amp;gt;150) or self-reported AUB. AUB-related quality of life (QoL) was assessed at baseline and the end of follow-up using the Menstrual Bleeding Questionnaire. The study was terminated early because of slow recruitment attributable to the COVID-19 pandemic. Of the 98 women, 65 (66%) met at least one of the 3 definitions of AUB during follow-up (95% confidence interval [CI], 57%-75%). AUB occurred in 60% of women (36 of 60) without AUB before VTE diagnosis (new-onset AUB; 95% CI, 47%-71%). Overall, QoL decreased over time, with a mean Menstrual Bleeding Questionnaire score increase of 5.1 points (95% CI, 2.2-7.9), but this decrease in QoL was observed only among women with new-onset AUB. To conclude, 2 of every 3\u00a0women who start anticoagulation for acute VTE experience AUB, with a considerable negative impact on QoL. These findings should be a call to action to increase awareness and provide evidence-based strategies to prevent and treat AUB in this setting. This was an academic study registered at www.clinicaltrials.gov as #NCT04748393; no funding was received.<\/jats:p>","DOI":"10.1182\/blood.2022017101","type":"journal-article","created":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T12:06:33Z","timestamp":1659614793000},"page":"1764-1773","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":55,"title":["Incidence and impact of anticoagulation-associated abnormal menstrual bleeding in women after venous thromboembolism"],"prefix":"10.1182","volume":"140","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2310-5820","authenticated-orcid":false,"given":"C.M.M.","family":"de Jong","sequence":"first","affiliation":[{"name":"1Department of Medicine\u2013Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7032-9491","authenticated-orcid":false,"given":"M.","family":"Blondon","sequence":"additional","affiliation":[{"name":"2Division of Angiology and Hemostasis, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2607-9717","authenticated-orcid":false,"given":"C.","family":"Ay","sequence":"additional","affiliation":[{"name":"3Clinical Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4254-5362","authenticated-orcid":false,"given":"A.","family":"Buchmuller","sequence":"additional","affiliation":[{"name":"4Service de M\u00e9decine Vasculaire et Th\u00e9rapeutique, INSERM, Centre d\u2019Investigation Clinique 1408, Investigation Network on Venous Thrombo-Embolism, Centre Hospitalier Universitaire (CHU) de St-Etienne, Saint-Etienne, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Beyer-Westendorf","sequence":"additional","affiliation":[{"name":"5Division of Hematology and Hemostasis, Department of Medicine I, University Hospital Carl Gustav Carus, Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Biechele","sequence":"additional","affiliation":[{"name":"6Department of Angiology, Universit\u00e4tsspital Basel, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8214-3010","authenticated-orcid":false,"given":"L.","family":"Bertoletti","sequence":"additional","affiliation":[{"name":"4Service de M\u00e9decine Vasculaire et Th\u00e9rapeutique, INSERM, Centre d\u2019Investigation Clinique 1408, Investigation Network on Venous Thrombo-Embolism, Centre Hospitalier Universitaire (CHU) de St-Etienne, Saint-Etienne, France"},{"name":"7INSERM, Unit\u00e9 Mixte de Recherche (UMR) 1059, Universit\u00e9 Jean-Monnet, Saint-Etienne, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Colombo","sequence":"additional","affiliation":[{"name":"8Research Centre on Thromboembolic Disorders and Antithrombotic Therapies, University of Insubria, Varese, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.P.","family":"Donadini","sequence":"additional","affiliation":[{"name":"9Department of Medicine and Surgery, Research Centre on Thromboembolic Disorders and Antithrombotic Therapies, University of Insubria, Varese, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3753-5565","authenticated-orcid":false,"given":"S.V.","family":"Hendriks","sequence":"additional","affiliation":[{"name":"1Department of Medicine\u2013Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4125-3376","authenticated-orcid":false,"given":"L.","family":"Jara-Palomares","sequence":"additional","affiliation":[{"name":"10Medical Surgical Unit of Respiratory Diseases, Virgen del Rocio Hospital, Seville, Spain"},{"name":"11Centro de Investigaci\u00f3n Biom\u00e9dica en Red Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4504-482X","authenticated-orcid":false,"given":"S.","family":"Nopp","sequence":"additional","affiliation":[{"name":"3Clinical Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5680-9883","authenticated-orcid":false,"given":"P.","family":"Ruiz-Artacho","sequence":"additional","affiliation":[{"name":"11Centro de Investigaci\u00f3n Biom\u00e9dica en Red Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain"},{"name":"12Department of Internal Medicine, Cl\u00ednica Universidad de Navarra, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Stephan","sequence":"additional","affiliation":[{"name":"13Department of Internal Medicine and Chest Diseases, Groupe d\u2019Etude de la Thrombose de Bretagne Occidentale, UMR 1304, Centre Hospitalier Universitaire (CHU) de Brest, Brest, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9161-7521","authenticated-orcid":false,"given":"C.","family":"Tromeur","sequence":"additional","affiliation":[{"name":"13Department of Internal Medicine and Chest Diseases, Groupe d\u2019Etude de la Thrombose de Bretagne Occidentale, UMR 1304, Centre Hospitalier Universitaire (CHU) de Brest, Brest, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Vanassche","sequence":"additional","affiliation":[{"name":"14Department of Cardiovascular Sciences, University Hospital Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0746-7039","authenticated-orcid":false,"given":"P.E.","family":"Westerweel","sequence":"additional","affiliation":[{"name":"15Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9961-0754","authenticated-orcid":false,"given":"F.A.","family":"Klok","sequence":"additional","affiliation":[{"name":"1Department of Medicine\u2013Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"3","key":"2022121921582124900_bib1","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1524-4733.2007.00168.x","article-title":"A\u00a0systematic review evaluating health-related quality of life, work impairment, and health-care costs and utilization in abnormal uterine bleeding","volume":"10","author":"Liu","year":"2007","journal-title":"Value Health"},{"key":"2022121921582124900_bib2","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.bpobgyn.2015.11.012","article-title":"Abnormal uterine bleeding","volume":"34","author":"Whitaker","year":"2016","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"suppl 1","key":"2022121921582124900_bib3","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1016\/S0049-3848(17)30072-5","article-title":"Heavy menstrual bleeding: an update on management","volume":"151","author":"Davies","year":"2017","journal-title":"Thromb Res"},{"key":"2022121921582124900_bib4","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.thromres.2017.03.013","article-title":"Oral contraception and menstrual bleeding during\u00a0treatment of venous thromboembolism: expert opinion versus current practice: combined results of a systematic review, expert panel opinion and an international survey","volume":"153","author":"Klok","year":"2017","journal-title":"Thromb Res"},{"issue":"1","key":"2022121921582124900_bib5","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ajog.2021.08.051","article-title":"Incidence of severe uterine bleeding outcomes among oral anticoagulant users and nonusers","volume":"226","author":"Huang","year":"2022","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"2022121921582124900_bib6","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s40264-021-01072-0","article-title":"Risk of severe abnormal uterine bleeding associated with rivaroxaban compared with apixaban, dabigatran and warfarin","volume":"44","author":"Eworuke","year":"2021","journal-title":"Drug Saf"},{"issue":"4","key":"2022121921582124900_bib7","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s40264-021-01060-4","article-title":"Comparative risk assessment of severe uterine bleeding following exposure to direct oral anticoagulants: a network study across four observational databases in the USA","volume":"44","author":"Weaver","year":"2021","journal-title":"Drug Saf"},{"issue":"2","key":"2022121921582124900_bib8","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/bjh.13583","article-title":"Heavy menstrual bleeding on rivaroxaban","volume":"173","author":"Ferreira","year":"2016","journal-title":"Br J Haematol"},{"issue":"6","key":"2022121921582124900_bib9","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1160\/TH15-11-0902","article-title":"Vaginal bleeding and heavy menstrual bleeding during direct oral anti-Xa inhibitor therapy","volume":"115","author":"Beyer-Westendorf","year":"2016","journal-title":"Thromb Haemost"},{"issue":"10","key":"2022121921582124900_bib10","doi-asserted-by":"crossref","first-page":"e480","DOI":"10.1016\/S2352-3026(16)30111-9","article-title":"Management and outcomes of vaginal bleeding and heavy menstrual bleeding in women of reproductive age on direct oral anti-factor Xa inhibitor therapy: a case series","volume":"3","author":"Beyer-Westendorf","year":"2016","journal-title":"Lancet Haematol"},{"issue":"11","key":"2022121921582124900_bib11","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1182\/blood-2015-08-665927","article-title":"Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use","volume":"127","author":"Martinelli","year":"2016","journal-title":"Blood"},{"issue":"5","key":"2022121921582124900_bib12","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/bjh.14003","article-title":"Heavy menstrual bleeding on rivaroxaban - comparison with apixaban","volume":"176","author":"Myers","year":"2017","journal-title":"Br\u00a0J Haematol"},{"key":"2022121921582124900_bib13","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.vph.2016.11.003","article-title":"Heavy menstrual bleeding in women treated with rivaroxaban and vitamin K antagonists and the risk of recurrent venous thromboembolism","volume":"87","author":"Bryk","year":"2016","journal-title":"Vascul Pharmacol"},{"issue":"2","key":"2022121921582124900_bib14","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.thromres.2013.07.017","article-title":"Do women bleed more than men when prescribed novel oral anticoagulants for venous thromboembolism? A sex-based meta-analysis","volume":"132","author":"Alotaibi","year":"2013","journal-title":"Thromb Res"},{"issue":"4","key":"2022121921582124900_bib15","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.thromres.2015.07.030","article-title":"Abnormal uterine bleeding in VTE patients treated with rivaroxaban compared to vitamin K antagonists","volume":"136","author":"De Crem","year":"2015","journal-title":"Thromb Res"},{"issue":"9","key":"2022121921582124900_bib16","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1111\/jth.14226","article-title":"Less abnormal uterine bleeding with dabigatran than warfarin in women treated for acute venous thromboembolism","volume":"16","author":"Huisman","year":"2018","journal-title":"J\u00a0Thromb Haemost"},{"issue":"12","key":"2022121921582124900_bib17","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1111\/1471-0528.15388","article-title":"Abnormal vaginal bleeding in women of reproductive age treated with edoxaban or warfarin for venous thromboembolism: a post hoc analysis of the Hokusai-VTE study","volume":"125","author":"Scheres","year":"2018","journal-title":"BJOG"},{"issue":"4","key":"2022121921582124900_bib18","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1160\/TH16-11-0874","article-title":"Abnormal vaginal bleeding in women with venous thromboembolism treated with apixaban or warfarin","volume":"117","author":"Brekelmans","year":"2017","journal-title":"Thromb Haemost"},{"issue":"9","key":"2022121921582124900_bib19","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1111\/j.1538-7836.2010.03975.x","article-title":"ISTH\/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders","volume":"8","author":"Rodeghiero","year":"2010","journal-title":"J\u00a0Thromb Haemost"},{"issue":"6","key":"2022121921582124900_bib20","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/hae.12503","article-title":"Normal range of bleeding scores for the ISTH-BAT: adult and pediatric data from the merging project","volume":"20","author":"Elbatarny","year":"2014","journal-title":"Haemophilia"},{"issue":"5","key":"2022121921582124900_bib21","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/1471-0528.13273","article-title":"The menstrual bleeding questionnaire: development and validation of a comprehensive patient-reported outcome instrument for heavy menstrual bleeding","volume":"122","author":"Matteson","year":"2015","journal-title":"BJOG"},{"issue":"8","key":"2022121921582124900_bib22","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1471-0528.1990.tb16249.x","article-title":"Assessment of menstrual blood loss using a pictorial chart","volume":"97","author":"Higham","year":"1990","journal-title":"Br J Obstet Gynaecol"},{"issue":"7","key":"2022121921582124900_bib23","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1055\/s-0036-1592304","article-title":"Direct oral anticoagulants and women","volume":"42","author":"Cohen","year":"2016","journal-title":"Semin Thromb Hemost"},{"issue":"3","key":"2022121921582124900_bib24","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ijgo.2006.07.004","article-title":"Levonorgestrel-releasing intrauterine system vs. transcervical endometrial resection for dysfunctional uterine bleeding","volume":"95","author":"Gupta","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"issue":"2","key":"2022121921582124900_bib25","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1365-2141.2009.07610.x","article-title":"Multisite management study of menorrhagia with abnormal laboratory haemostasis: a prospective crossover study of intranasal desmopressin and oral tranexamic acid","volume":"145","author":"Kouides","year":"2009","journal-title":"Br J Haematol"},{"issue":"5","key":"2022121921582124900_bib26","doi-asserted-by":"crossref","first-page":"e632","DOI":"10.1111\/hae.14373","article-title":"Validation of the pictorial blood loss assessment chart using modern sanitary products","volume":"27","author":"Spence","year":"2021","journal-title":"Haemophilia"},{"issue":"3","key":"2022121921582124900_bib27","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1471-0528.2006.00863.x","article-title":"A\u00a0randomised trial comparing the levonorgestrel intrauterine system and thermal balloon ablation for heavy menstrual bleeding","volume":"113","author":"Busfield","year":"2006","journal-title":"BJOG"},{"issue":"4","key":"2022121921582124900_bib28","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000320336","article-title":"Pictorial blood loss assessment chart in the evaluation of heavy menstrual bleeding: diagnostic accuracy compared to alkaline hematin","volume":"71","author":"Zakherah","year":"2011","journal-title":"Gynecol Obstet Invest"},{"issue":"2","key":"2022121921582124900_bib29","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/1471-0528.14434","article-title":"Is the pictorial blood loss assessment chart (PBAC) score associated with treatment outcome after endometrial ablation for heavy menstrual bleeding? A cohort study","volume":"124","author":"Herman","year":"2017","journal-title":"BJOG"},{"issue":"3","key":"2022121921582124900_bib30","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/ijgo.12666","article-title":"The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions","volume":"143","author":"Munro","year":"2018","journal-title":"Int J Gynaecol Obstet"},{"key":"2022121921582124900_bib31","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.bpobgyn.2016.09.009","article-title":"Menstrual questionnaires for clinical and research use","volume":"40","author":"Matteson","year":"2017","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"2","key":"2022121921582124900_bib32","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.contraception.2010.12.011","article-title":"Menstrual problems and contraception in women of reproductive age receiving oral anticoagulation","volume":"84","author":"Huq","year":"2011","journal-title":"Contraception"},{"issue":"1","key":"2022121921582124900_bib33","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11239-006-0003-7","article-title":"Menorrhagia and minor bleeding symptoms in women on oral anticoagulation","volume":"24","author":"Sj\u00e4lander","year":"2007","journal-title":"J\u00a0Thromb Thrombolysis"},{"issue":"suppl 1","key":"2022121921582124900_bib34","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0049-3848(19)30357-3","article-title":"Optimal management of hormonal contraceptives after an episode of venous thromboembolism","volume":"181","author":"Klok","year":"2019","journal-title":"Thromb Res"},{"issue":"1","key":"2022121921582124900_bib35","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/AOG.0b013e318262e320","article-title":"Practice bulletin no. 128: diagnosis of abnormal uterine bleeding in reproductive-aged women","volume":"120","author":"Committee on Practice Bulletins\u2014Gynecology","year":"2012","journal-title":"Obstet Gynecol"},{"issue":"7","key":"2022121921582124900_bib36","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1471-0528.2004.00176.x","article-title":"von Willebrand disease in women with menorrhagia: a systematic review","volume":"111","author":"Shankar","year":"2004","journal-title":"BJOG"},{"issue":"6","key":"2022121921582124900_bib37","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1016\/j.chest.2021.01.071","article-title":"Quality of life 3 and 12 months following acute pulmonary embolism: analysis from a prospective multicenter cohort study","volume":"159","author":"Valerio","year":"2021","journal-title":"Chest"},{"key":"2022121921582124900_bib38","unstructured":"Kline\n              J\n            \n          . RAMBLE - rivaroxaban vs. apixaban for heavy menstrual bleeding (RAMBLE). ClinicalTrials.gov. Updated 6 December 2019. Accessed 26 April 2022. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02829957."},{"issue":"1","key":"2022121921582124900_bib39","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/rth2.12471","article-title":"Heavy menstrual bleeding on direct factor Xa inhibitors: rationale and design of the MEDEA study","volume":"5","author":"Hamuly\u00e1k","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"issue":"3","key":"2022121921582124900_bib40","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/eurheartj\/ehab816","article-title":"Optimal follow-up after acute pulmonary embolism: a position paper of the European Society of Cardiology Working Group on Pulmonary Circulation and Right Ventricular Function, in collaboration with the European Society of Cardiology Working Group on Atherosclerosis and Vascular Biology, endorsed by the European Respiratory Society","volume":"43","author":"Klok","year":"2022","journal-title":"Eur Heart J"},{"issue":"24","key":"2022121921582124900_bib41","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1182\/blood-2017-07-797423","article-title":"How I treat heavy menstrual bleeding associated with anticoagulants","volume":"130","author":"Boonyawat","year":"2017","journal-title":"Blood"},{"issue":"4","key":"2022121921582124900_bib42","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1538-7836.2012.04662.x","article-title":"Duration of anticoagulant therapy after a first episode of an unprovoked pulmonary embolus or deep vein thrombosis: guidance from the SSC of the ISTH","volume":"10","author":"Baglin","year":"2012","journal-title":"J\u00a0Thromb Haemost"},{"issue":"10","key":"2022121921582124900_bib43","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1182\/blood.2019001605","article-title":"How I assess and manage the risk of bleeding in patients treated for venous thromboembolism","volume":"135","author":"Klok","year":"2020","journal-title":"Blood"},{"issue":"2","key":"2022121921582124900_bib44","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/rth2.12474","article-title":"Heavy menstrual bleeding in women on anticoagulant treatment for venous thromboembolism: comparison of high- and low-dose rivaroxaban with aspirin","volume":"5","author":"Boonyawat","year":"2021","journal-title":"Res Pract Thromb Haemost"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/140\/16\/1764\/1927519\/blood_bld-2022-017101-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/140\/16\/1764\/1927519\/blood_bld-2022-017101-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T16:58:45Z","timestamp":1671469125000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/140\/16\/1764\/486115\/Incidence-and-impact-of-anticoagulation-associated"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,20]]},"references-count":44,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2022,10,20]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2022017101","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,20]]}}}